Indication
Carbapenem Resistant Bacterial Infection
2 clinical trials
5 products
Clinical trial
Cefiderocol and Ampicillin-sulbactam vs. Colistin or Colistin-meropenem for Carbapenem Resistant Acinetobacter Baumannii Bacteremia or Hospital-acquired Pneumonia: Controlled Clinical Study With Historical Controls (CASCADE)Status: Not yet recruiting, Estimated PCD: 2026-07-01
Product
CefiderocolProduct
Ampicillin-sulbactamProduct
ColistinProduct
MeropenemClinical trial
Clinical Study on the Efficacy and Safety of Carrimycin Tablets in Hemophagocytic Lymphohistiocytosis Patients With Carbapenem-resistant InfectionsStatus: Not yet recruiting, Estimated PCD: 2026-08-30
Product
Carrimycin